0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI Clinical Trial Imaging Market Research Report 2026
Published Date: 2026-01-30
|
Report Code: QYRE-Auto-0W18807
Home | Market Reports | Health| Health Foundations & Medical Research
Global AI Clinical Trial Imaging Market Research Report 2024
BUY CHAPTERS

Global AI Clinical Trial Imaging Market Research Report 2026

Code: QYRE-Auto-0W18807
Report
2026-01-30
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI Clinical Trial Imaging Market

The global AI Clinical Trial Imaging market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
AI Clinical Trial Imaging refers to a technology that uses artificial intelligence technology to process, analyze and interpret medical imaging data to assist doctors in disease diagnosis, treatment planning and patient management. It combines the algorithmic advantages of artificial intelligence with the intuitiveness of medical imaging to improve the accuracy and efficiency of diagnosis.
The North American market for AI Clinical Trial Imaging is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for AI Clinical Trial Imaging is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for AI Clinical Trial Imaging in Telemedicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of AI Clinical Trial Imaging include AICure, Brainomix, Clario, Lantern Pharma, Median, Neuroute, Owkin, PathAI, Quibim, Saama, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global AI Clinical Trial Imaging market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Clinical Trial Imaging. The AI Clinical Trial Imaging market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AI Clinical Trial Imaging market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AI Clinical Trial Imaging manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of AI Clinical Trial Imaging Market Report

Report Metric Details
Report Name AI Clinical Trial Imaging Market
Segment by Type
  • Based on Machine Learning
  • Based on Deep Learning
  • Others
Segment by Application
  • Telemedicine
  • Diagnostic Assistance
  • Clinical Decision Support
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AICure, Brainomix, Clario, Lantern Pharma, Median, Neuroute, Owkin, PathAI, Quibim, Saama, Spectral, VIDA, Voiant
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for AI Clinical Trial Imaging companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the AI Clinical Trial Imaging Market report?

Ans: The main players in the AI Clinical Trial Imaging Market are AICure, Brainomix, Clario, Lantern Pharma, Median, Neuroute, Owkin, PathAI, Quibim, Saama, Spectral, VIDA, Voiant

What are the Application segmentation covered in the AI Clinical Trial Imaging Market report?

Ans: The Applications covered in the AI Clinical Trial Imaging Market report are Telemedicine, Diagnostic Assistance, Clinical Decision Support, Others

What are the Type segmentation covered in the AI Clinical Trial Imaging Market report?

Ans: The Types covered in the AI Clinical Trial Imaging Market report are Based on Machine Learning, Based on Deep Learning, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Clinical Trial Imaging Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Based on Machine Learning
1.2.3 Based on Deep Learning
1.2.4 Others
1.3 Market by Application
1.3.1 Global AI Clinical Trial Imaging Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Telemedicine
1.3.3 Diagnostic Assistance
1.3.4 Clinical Decision Support
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Clinical Trial Imaging Market Perspective (2021–2032)
2.2 Global AI Clinical Trial Imaging Growth Trends by Region
2.2.1 Global AI Clinical Trial Imaging Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AI Clinical Trial Imaging Historic Market Size by Region (2021–2026)
2.2.3 AI Clinical Trial Imaging Forecasted Market Size by Region (2027–2032)
2.3 AI Clinical Trial Imaging Market Dynamics
2.3.1 AI Clinical Trial Imaging Industry Trends
2.3.2 AI Clinical Trial Imaging Market Drivers
2.3.3 AI Clinical Trial Imaging Market Challenges
2.3.4 AI Clinical Trial Imaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Clinical Trial Imaging Players by Revenue
3.1.1 Global Top AI Clinical Trial Imaging Players by Revenue (2021–2026)
3.1.2 Global AI Clinical Trial Imaging Revenue Market Share by Players (2021–2026)
3.2 Global Top AI Clinical Trial Imaging Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AI Clinical Trial Imaging Revenue
3.4 Global AI Clinical Trial Imaging Market Concentration Ratio
3.4.1 Global AI Clinical Trial Imaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Clinical Trial Imaging Revenue in 2025
3.5 Global Key Players of AI Clinical Trial Imaging Head Offices and Areas Served
3.6 Global Key Players of AI Clinical Trial Imaging, Products and Applications
3.7 Global Key Players of AI Clinical Trial Imaging, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AI Clinical Trial Imaging Breakdown Data by Type
4.1 Global AI Clinical Trial Imaging Historic Market Size by Type (2021–2026)
4.2 Global AI Clinical Trial Imaging Forecasted Market Size by Type (2027–2032)
5 AI Clinical Trial Imaging Breakdown Data by Application
5.1 Global AI Clinical Trial Imaging Historic Market Size by Application (2021–2026)
5.2 Global AI Clinical Trial Imaging Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AI Clinical Trial Imaging Market Size (2021–2032)
6.2 North America AI Clinical Trial Imaging Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AI Clinical Trial Imaging Market Size by Country (2021–2026)
6.4 North America AI Clinical Trial Imaging Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Clinical Trial Imaging Market Size (2021–2032)
7.2 Europe AI Clinical Trial Imaging Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AI Clinical Trial Imaging Market Size by Country (2021–2026)
7.4 Europe AI Clinical Trial Imaging Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI Clinical Trial Imaging Market Size (2021–2032)
8.2 Asia-Pacific AI Clinical Trial Imaging Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AI Clinical Trial Imaging Market Size by Region (2021–2026)
8.4 Asia-Pacific AI Clinical Trial Imaging Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI Clinical Trial Imaging Market Size (2021–2032)
9.2 Latin America AI Clinical Trial Imaging Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AI Clinical Trial Imaging Market Size by Country (2021–2026)
9.4 Latin America AI Clinical Trial Imaging Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Clinical Trial Imaging Market Size (2021–2032)
10.2 Middle East & Africa AI Clinical Trial Imaging Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AI Clinical Trial Imaging Market Size by Country (2021–2026)
10.4 Middle East & Africa AI Clinical Trial Imaging Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AICure
11.1.1 AICure Company Details
11.1.2 AICure Business Overview
11.1.3 AICure AI Clinical Trial Imaging Introduction
11.1.4 AICure Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.1.5 AICure Recent Development
11.2 Brainomix
11.2.1 Brainomix Company Details
11.2.2 Brainomix Business Overview
11.2.3 Brainomix AI Clinical Trial Imaging Introduction
11.2.4 Brainomix Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.2.5 Brainomix Recent Development
11.3 Clario
11.3.1 Clario Company Details
11.3.2 Clario Business Overview
11.3.3 Clario AI Clinical Trial Imaging Introduction
11.3.4 Clario Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.3.5 Clario Recent Development
11.4 Lantern Pharma
11.4.1 Lantern Pharma Company Details
11.4.2 Lantern Pharma Business Overview
11.4.3 Lantern Pharma AI Clinical Trial Imaging Introduction
11.4.4 Lantern Pharma Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.4.5 Lantern Pharma Recent Development
11.5 Median
11.5.1 Median Company Details
11.5.2 Median Business Overview
11.5.3 Median AI Clinical Trial Imaging Introduction
11.5.4 Median Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.5.5 Median Recent Development
11.6 Neuroute
11.6.1 Neuroute Company Details
11.6.2 Neuroute Business Overview
11.6.3 Neuroute AI Clinical Trial Imaging Introduction
11.6.4 Neuroute Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.6.5 Neuroute Recent Development
11.7 Owkin
11.7.1 Owkin Company Details
11.7.2 Owkin Business Overview
11.7.3 Owkin AI Clinical Trial Imaging Introduction
11.7.4 Owkin Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.7.5 Owkin Recent Development
11.8 PathAI
11.8.1 PathAI Company Details
11.8.2 PathAI Business Overview
11.8.3 PathAI AI Clinical Trial Imaging Introduction
11.8.4 PathAI Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.8.5 PathAI Recent Development
11.9 Quibim
11.9.1 Quibim Company Details
11.9.2 Quibim Business Overview
11.9.3 Quibim AI Clinical Trial Imaging Introduction
11.9.4 Quibim Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.9.5 Quibim Recent Development
11.10 Saama
11.10.1 Saama Company Details
11.10.2 Saama Business Overview
11.10.3 Saama AI Clinical Trial Imaging Introduction
11.10.4 Saama Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.10.5 Saama Recent Development
11.11 Spectral
11.11.1 Spectral Company Details
11.11.2 Spectral Business Overview
11.11.3 Spectral AI Clinical Trial Imaging Introduction
11.11.4 Spectral Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.11.5 Spectral Recent Development
11.12 VIDA
11.12.1 VIDA Company Details
11.12.2 VIDA Business Overview
11.12.3 VIDA AI Clinical Trial Imaging Introduction
11.12.4 VIDA Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.12.5 VIDA Recent Development
11.13 Voiant
11.13.1 Voiant Company Details
11.13.2 Voiant Business Overview
11.13.3 Voiant AI Clinical Trial Imaging Introduction
11.13.4 Voiant Revenue in AI Clinical Trial Imaging Business (2021–2026)
11.13.5 Voiant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global AI Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Based on Machine Learning
 Table 3. Key Players of Based on Deep Learning
 Table 4. Key Players of Others
 Table 5. Global AI Clinical Trial Imaging Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global AI Clinical Trial Imaging Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global AI Clinical Trial Imaging Market Size by Region (US$ Million), 2021–2026
 Table 8. Global AI Clinical Trial Imaging Market Share by Region (2021–2026)
 Table 9. Global AI Clinical Trial Imaging Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global AI Clinical Trial Imaging Market Share by Region (2027–2032)
 Table 11. AI Clinical Trial Imaging Market Trends
 Table 12. AI Clinical Trial Imaging Market Drivers
 Table 13. AI Clinical Trial Imaging Market Challenges
 Table 14. AI Clinical Trial Imaging Market Restraints
 Table 15. Global AI Clinical Trial Imaging Revenue by Players (US$ Million), 2021–2026
 Table 16. Global AI Clinical Trial Imaging Market Share by Players (2021–2026)
 Table 17. Global Top AI Clinical Trial Imaging Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Clinical Trial Imaging Revenue, 2025
 Table 18. Ranking of Global Top AI Clinical Trial Imaging Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by AI Clinical Trial Imaging Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of AI Clinical Trial Imaging, Headquarters and Area Served
 Table 21. Global Key Players of AI Clinical Trial Imaging, Products and Applications
 Table 22. Global Key Players of AI Clinical Trial Imaging, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global AI Clinical Trial Imaging Market Size by Type (US$ Million), 2021–2026
 Table 25. Global AI Clinical Trial Imaging Revenue Market Share by Type (2021–2026)
 Table 26. Global AI Clinical Trial Imaging Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global AI Clinical Trial Imaging Revenue Market Share by Type (2027–2032)
 Table 28. Global AI Clinical Trial Imaging Market Size by Application (US$ Million), 2021–2026
 Table 29. Global AI Clinical Trial Imaging Revenue Market Share by Application (2021–2026)
 Table 30. Global AI Clinical Trial Imaging Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global AI Clinical Trial Imaging Revenue Market Share by Application (2027–2032)
 Table 32. North America AI Clinical Trial Imaging Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America AI Clinical Trial Imaging Market Size by Country (US$ Million), 2021–2026
 Table 34. North America AI Clinical Trial Imaging Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe AI Clinical Trial Imaging Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe AI Clinical Trial Imaging Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe AI Clinical Trial Imaging Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific AI Clinical Trial Imaging Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific AI Clinical Trial Imaging Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific AI Clinical Trial Imaging Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America AI Clinical Trial Imaging Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America AI Clinical Trial Imaging Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America AI Clinical Trial Imaging Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa AI Clinical Trial Imaging Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa AI Clinical Trial Imaging Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa AI Clinical Trial Imaging Market Size by Country (US$ Million), 2027–2032
 Table 47. AICure Company Details
 Table 48. AICure Business Overview
 Table 49. AICure AI Clinical Trial Imaging Product
 Table 50. AICure Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 51. AICure Recent Development
 Table 52. Brainomix Company Details
 Table 53. Brainomix Business Overview
 Table 54. Brainomix AI Clinical Trial Imaging Product
 Table 55. Brainomix Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 56. Brainomix Recent Development
 Table 57. Clario Company Details
 Table 58. Clario Business Overview
 Table 59. Clario AI Clinical Trial Imaging Product
 Table 60. Clario Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 61. Clario Recent Development
 Table 62. Lantern Pharma Company Details
 Table 63. Lantern Pharma Business Overview
 Table 64. Lantern Pharma AI Clinical Trial Imaging Product
 Table 65. Lantern Pharma Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 66. Lantern Pharma Recent Development
 Table 67. Median Company Details
 Table 68. Median Business Overview
 Table 69. Median AI Clinical Trial Imaging Product
 Table 70. Median Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 71. Median Recent Development
 Table 72. Neuroute Company Details
 Table 73. Neuroute Business Overview
 Table 74. Neuroute AI Clinical Trial Imaging Product
 Table 75. Neuroute Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 76. Neuroute Recent Development
 Table 77. Owkin Company Details
 Table 78. Owkin Business Overview
 Table 79. Owkin AI Clinical Trial Imaging Product
 Table 80. Owkin Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 81. Owkin Recent Development
 Table 82. PathAI Company Details
 Table 83. PathAI Business Overview
 Table 84. PathAI AI Clinical Trial Imaging Product
 Table 85. PathAI Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 86. PathAI Recent Development
 Table 87. Quibim Company Details
 Table 88. Quibim Business Overview
 Table 89. Quibim AI Clinical Trial Imaging Product
 Table 90. Quibim Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 91. Quibim Recent Development
 Table 92. Saama Company Details
 Table 93. Saama Business Overview
 Table 94. Saama AI Clinical Trial Imaging Product
 Table 95. Saama Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 96. Saama Recent Development
 Table 97. Spectral Company Details
 Table 98. Spectral Business Overview
 Table 99. Spectral AI Clinical Trial Imaging Product
 Table 100. Spectral Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 101. Spectral Recent Development
 Table 102. VIDA Company Details
 Table 103. VIDA Business Overview
 Table 104. VIDA AI Clinical Trial Imaging Product
 Table 105. VIDA Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 106. VIDA Recent Development
 Table 107. Voiant Company Details
 Table 108. Voiant Business Overview
 Table 109. Voiant AI Clinical Trial Imaging Product
 Table 110. Voiant Revenue in AI Clinical Trial Imaging Business (US$ Million), 2021–2026
 Table 111. Voiant Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. AI Clinical Trial Imaging Picture
 Figure 2. Global AI Clinical Trial Imaging Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global AI Clinical Trial Imaging Market Share by Type: 2025 vs 2032
 Figure 4. Based on Machine Learning Features
 Figure 5. Based on Deep Learning Features
 Figure 6. Others Features
 Figure 7. Global AI Clinical Trial Imaging Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global AI Clinical Trial Imaging Market Share by Application: 2025 vs 2032
 Figure 9. Telemedicine Case Studies
 Figure 10. Diagnostic Assistance Case Studies
 Figure 11. Clinical Decision Support Case Studies
 Figure 12. Others Case Studies
 Figure 13. AI Clinical Trial Imaging Report Years Considered
 Figure 14. Global AI Clinical Trial Imaging Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global AI Clinical Trial Imaging Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global AI Clinical Trial Imaging Market Share by Region: 2025 vs 2032
 Figure 17. Global AI Clinical Trial Imaging Market Share by Players in 2025
 Figure 18. Global AI Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by AI Clinical Trial Imaging Revenue in 2025
 Figure 20. North America AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America AI Clinical Trial Imaging Market Share by Country (2021–2032)
 Figure 22. United States AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe AI Clinical Trial Imaging Market Share by Country (2021–2032)
 Figure 26. Germany AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific AI Clinical Trial Imaging Market Share by Region (2021–2032)
 Figure 34. China AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America AI Clinical Trial Imaging Market Share by Country (2021–2032)
 Figure 42. Mexico AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa AI Clinical Trial Imaging Market Share by Country (2021–2032)
 Figure 46. Israel AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE AI Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. AICure Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 50. Brainomix Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 51. Clario Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 52. Lantern Pharma Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 53. Median Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 54. Neuroute Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 55. Owkin Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 56. PathAI Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 57. Quibim Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 58. Saama Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 59. Spectral Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 60. VIDA Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 61. Voiant Revenue Growth Rate in AI Clinical Trial Imaging Business (2021–2026)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools